Literature DB >> 25689220

Maternal X chromosome copy number variations are associated with discordant fetal sex chromosome aneuploidies detected by noninvasive prenatal testing.

Shaowei Wang1, Shuai Huang2, Linlin Ma2, Lin Liang2, Junrong Zhang2, Jianguang Zhang3, David S Cram4.   

Abstract

BACKGROUND: The sensitivity and specificity of noninvasive prenatal testing (NIPT) for detection of sex chromosome aneuploidies (SCAs) compared to common autosomal trisomies are significantly lower. We speculated that in addition to altered maternal X chromosome karyotype, maternal X chromosome copy number variations (CNVs) may also contribute to discordant NIPT SCA results.
METHODS: Clinical NIPT was performed for pregnant women at a single hospital. Copy number variation sequencing (CNV-Seq) was used to identify and quantitate the copy number of maternal X chromosome CNVs for each positive SCA pregnancy.
RESULTS: Two out of 25 SCA positive NIPT samples had slightly abnormal ChrX/ChrY z-scores and were referred for invasive test confirmation. However, fetal karyotypes were found to be normal. CNV-Seq analysis of the maternal white blood cell DNA archived from the original two NIPT blood samples identified small CNVs spanning the STS gene, which is associated with X-linked ichthyosis. Correcting for the altered plasma levels of X chromosome DNA caused by the two CNVs and, taking into consideration the phenotypic consequences for X-linked disease, both fetuses were diagnosed as normal.
CONCLUSIONS: Maternal DNA sequencing is recommended for all positive NIPT SCA results to avoid unnecessary referral for invasive testing and also to evaluate the risk to the fetus of X-linked disease.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Copy number variation; Noninvasive prenatal diagnosis; Sequencing; Sex chromosome aneuploidy; X-linked disease

Mesh:

Year:  2015        PMID: 25689220     DOI: 10.1016/j.cca.2015.02.014

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

Review 1.  Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.

Authors:  Mylène Badeau; Carmen Lindsay; Jonatan Blais; Leon Nshimyumukiza; Yemisi Takwoingi; Sylvie Langlois; France Légaré; Yves Giguère; Alexis F Turgeon; William Witteman; François Rousseau
Journal:  Cochrane Database Syst Rev       Date:  2017-11-10

Review 2.  Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.

Authors:  Matthew R Grace; Emily Hardisty; Sarah K Dotters-Katz; Neeta L Vora; Jeffrey A Kuller
Journal:  Obstet Gynecol Surv       Date:  2016-08       Impact factor: 2.347

3.  Cell-free fetal DNA testing and its correlation with prenatal indications.

Authors:  Jing-Wei Wang; Yong-Nan Lyu; Bin Qiao; Yan Li; Yan Zhang; Pavan Kumar Dhanyamraju; Yevgeniya Bamme; Michael D Yu; Dongqin Yang; Yong-Qing Tong
Journal:  BMC Pregnancy Childbirth       Date:  2021-08-24       Impact factor: 3.007

4.  Cell-Based NIPT Detects 47,XXY Genotype in a Twin Pregnancy.

Authors:  Line Dahl Jeppesen; Tina Duelund Hjortshøj; Johnny Hindkjær; Lotte Hatt; Olav Bjørn Petersen; Ripudaman Singh; Palle Schelde; Lotte Andreasen; Rikke Christensen; Dorte L Lildballe; Ida Vogel
Journal:  Front Genet       Date:  2022-03-11       Impact factor: 4.599

5.  Systematic analysis of the causes of NIPS sex chromosome aneuploidy false-positive results.

Authors:  Zhaoru Lyu; Chunhong Huang
Journal:  Mol Genet Genomic Med       Date:  2022-05-10       Impact factor: 2.473

6.  Cell-free DNA screening for sex chromosomal aneuploidies in 9985 pregnancies: Italian single experience.

Authors:  Katia Margiotti; Anthony Cesta; Claudio Dello Russo; Antonella Cima; Maria Antonietta Barone; Antonella Viola; Davide Sparacino; Alvaro Mesoraca; Claudio Giorlandino
Journal:  BMC Res Notes       Date:  2020-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.